维普中文期刊产品整合服务
14篇 您的检索式:作者名="HABEB A"
    题名 作者 年代 出处 被引量
1Air flow and thermal efficiency characteristics in solar chimneys and Trombe walls 显示文摘BUREK S A M HABEB A 2007Energy and Buildings2007,39,2:1
2Air flow and thermal efficiency characteristics in solar chimneys and trombe walls显示文摘Burek S A M Habeb A 2007Energy and Buildings2007,39,2:1
3Air flow and thermal efficiency eharacter- istics in solar chimneys and Trombe Walls显示文摘Burek S A M Habeb A 2007Energy and Build- ings2007,39,2:1
4Air flow and thermal efficiency characteristics in solar chimneys and Trombe Walls 显示文摘Burek S A M Habeb A 2007Energy and Buildings2007,39,12:1
5Permanent neonatal diabetes : different aetiology in Arabs compared to Europeans显示文摘Habeb AM Flanagan SE Deeb A 2012Arch Dis Child2012,97,8:1
6Air flow and thermal effieieney charaeteristies in solar chimneys and Trombe Wall显示文摘Burek Sam Habeb A 2007Energy and Building2007,,39:1
7Air flow and thermal efficiency characteristics in solar chimneys and Trombe Wall 显示文摘Burek Sam Habeb A 2007Energy and Building2007,39,:1
8Air flow and thermal efficiency characteristics in solar chimneys and Trombe walls显示文摘Burek S A M Habeb A 2007Energy and Buildings2007,39,2:1
9Air flow and thermal efficiency characteristics in solar chimneys and Trombe walls 显示文摘Burek S A M Habeb A 2007Energy and Buildings2007,39,2:1
10Air flow and thermal efficiency characteristics in solar chimneys and Trombe walls显示文摘Burek S A M Habeb A 2007Energy and Buildings2007,39,2:1
11Airflow and thermal efficiency charac- teristics in solar chimneys and Trombe walls显示文摘Burek S A M Habeb A 2007Energy and Buildings2007,39,2:1
12Air flow and thermal efficiencycharacteristics in solar chimneys and Trombe walls显示文摘Burek S A M Habeb A 2007En-ergy and Buildings2007,39,2:1
13Air flow and thermal efficiency characteristics in solar chimneys and Trombe Walls显示文摘Burek S A Habeb A 2007Energy and Buildings2007,39,2:1
14Rationales and uncertainties for aspirin use in COVID-19:a narrative review显示文摘Objectives To review the pathophysiology of COVID-19 disease,potential aspirin targets on this pathogenesis and the potential role of aspirin in patients with COVID-19.Design Narrative review.Setting The online databases PubMed,OVID Medline and Cochrane Library were searched using relevant headlines from 1 January 2016 to 1 January 2021.International guidelines from relevant societies,journals and forums were also assessed for relevance.Participants Not applicable.Results A review of the selected literature revealed that clinical deterioration in COVID-19 is attributed to the interplay between endothelial dysfunction,coagulopathy and dysregulated inflammation.Aspirin has anti-inflammatory effects,antiplatelet aggregation,anticoagulant properties as well as pleiotropic effects on endothelial function.During the COVID-19 pandemic,low-dose aspirin is used effectively in secondary prevention of atherosclerotic cardiovascular disease,prevention of venous thromboembolism after total hip or knee replacement,prevention of pre-eclampsia and postdischarge treatment for multisystem inflammatory syndrome in children.Prehospital low-dose aspirin therapy may reduce the risk of intensive care unit admission and mechanical ventilation in hospitalised patients with COVID-19,whereas aspirin association with mortality is still debatable.Conclusion The authors recommend a low-dose aspirin regimen for primary prevention of arterial thromboembolism in patients aged 40-70 years who are at high atherosclerotic cardiovascular disease risk,or an intermediate risk with a risk-enhancer and have a low risk of bleeding.Aspirin’s protective roles in COVID-19 associated with acute lung injury,vascular thrombosis without previous cardiovascular disease and mortality need further randomised controlled trials to establish causal conclusions.Hazem A Sayed Ahmed Eric Merrell Mansoura Ismail Anwar I Joudeh Jeffrey B Riley Ahmed Shawkat Hanan Habeb Edward Darling Reda A Goweda Mohamed H Shehata Hossam Amin Gary F Nieman Hani Aiash 2021Family Medicine and Community Health2021,9,2:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费